Evolus, Inc.
(NASDAQ : EOLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.58%43.530.9%$854.99m
JNJJohnson & Johnson
0.45%134.470.6%$800.06m
MRKMerck & Co., Inc.
0.12%69.900.6%$564.98m
LLYEli Lilly and Company
0.32%110.831.0%$504.20m
ABBVAbbVie, Inc.
-1.08%89.712.2%$473.92m
BMYBristol-Myers Squibb Company
0.72%57.931.4%$331.08m
NVSNovartis AG Sponsored ADR
0.87%83.500.2%$164.47m
AZNAstraZeneca PLC Sponsored ADR
1.12%37.571.3%$138.37m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.21%42.440.1%$79.84m
GSKGlaxoSmithKline plc Sponsored ADR
1.93%39.050.2%$79.58m
SNYSanofi Sponsored ADR
1.42%43.500.2%$57.36m
LCILannett Company, Inc.
0.00%4.0337.0%$6.64m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.76%1.761.7%$0.14m
EPIXESSA Pharma Inc
1.53%3.680.1%$0.03m

Company Profile

Evolus, Inc. is a medical aesthetics company. The company is engaged in providing physicians and patients with expanded choices in aesthetic procedures and treatments. Evolus was founded in November, 2012 and is headquartered in Irvine, CA.